FDA Inspection 1231373 — ChemPacific Corporation

ChemPacific Corporation — FEI 3003299802

The FDA completed an inspection of ChemPacific Corporation on February 15, 2024 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baltimore, MD (United States)